Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5654-5662
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5654
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5654
Table 4 Multivariate analysis of baseline predictors of survival for each stage
Variable | BCLC A | BCLC B | ||
HR (95%CI) | P value | HR (95%CI) | P value | |
Number of tumor nodules > 1 | 1.82 (1.21-2.75) | 0.004 | - | - |
Maximum tumor diameter > 5 cm | 1.02 (0.49-2.13) | 0.942 | 2.95 (1.87-4.6) | < 0.001 |
Elevated Child score | 3.2 (2.12-4.87) | < 0.001 | 1.75 (1.27-2.42) | 0.001 |
AFP ≥ 200 ng/mL | 1.6 (1.11-2.32) | 0.012 | 1.3 (1.01-1.74) | 0.040 |
Presence of ascites | 1.7 (1.16-2.66) | 0.007 | 1.44 (1.03-2.04) | 0.030 |
- Citation: Gomaa AI, Al-Khatib A, Abdel-Razek W, Hashim MS, Waked I. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. World J Gastroenterol 2015; 21(18): 5654-5662
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5654.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5654